Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Edwards Lifesciences Corp shares valued at $2,285,355 were purchased by Wood Larry L on Nov 11 ’25. At $85.12 per share, Wood Larry L acquired 26,850 shares.
Also, Ullem Scott B. sold 13,000 shares, netting a total of over 1,080,093 in proceeds. Following the sale of shares at $83.08 each, the insider now holds 39,898 shares.
Before that, Lippis Daniel J. had sold 1,020 shares from its account. In a trade valued at $84,196, the CVP, JAPAC traded Edwards Lifesciences Corp shares for $82.55 each. Upon closing the transaction, the insider’s holdings decreased to 1,020 shares, worth approximately $1.89 million.
As published in a research note from Raymond James on November 03, 2025, Edwards Lifesciences Corp [EW] has been rated up from a Mkt perform to an Outperform and the price target has been revised to $96. Analysts at Wolfe Research upgraded the stock from ‘”an Underperform”‘ to ‘”a Peer perform”‘ outlook in a report released in late October. As of October 29, 2025, Jefferies has increased its “Hold” rating to a “Buy” for EW. Earlier on October 08, 2025, Oppenheimer downgraded its rating. Their new recommendation was “a Perform” for EW stock which previously was a “an Outperform”.
Analyzing EW Stock Performance
On last trading session, Edwards Lifesciences Corp [NYSE: EW] rose 0.62% to $86.11. The stock’s lowest price that day was $84.94, but it reached a high of $87.205 in the same session. During the last five days, there has been a surge of approximately 4.45%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 29.10%. Shares of the company reached a 52-week high of $87.21 on 11/13/25 and a 52-week low of $65.94 on 04/09/25.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
According to the 24-hour chart, there is a support level at 84.97, which, if violated, would cause prices to drop to 83.82. In the upper region, resistance lies at 87.23. The next price resistance is at 88.35. RSI (Relative Strength Index) is 72.91 on the 14-day chart, showing overbought technical sentiment.
Is Edwards Lifesciences Corp subject to short interest?
Stocks of Edwards Lifesciences Corp saw a sharp rise in short interest on 2025-10-31 jumping by 1.65 million shares to 9.12 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 7.46 million shares. A jump of 18.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.78 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.78.
Which companies own the most shares of Edwards Lifesciences Corp (EW)?
In terms of Edwards Lifesciences Corp share price expectations, FactSet research, analysts set an average price target of 90 in the next 12 months, up nearly 5.16% from the previous closing price of $85.58. Analysts anticipate Edwards Lifesciences Corp stock to reach 104 by 2025, with the lowest price target being 83. In spite of this, 17 analysts ranked Edwards Lifesciences Corp stock as Buy at the end of 2025. On October 07, 2025, Evercore ISI assigned a price target of “an Outperform” to the stock and upgraded coverage with a $88.
